INSIGHTS ON CLINICAL TRIAL DESIGN

• Lack Of IRT/RTSM System Reusability Surprises Every Clinical Trial Sponsor

  Stop re-learning your IRT system with every new trial. Uncover why "standard" features often hide custom complexities that slow down UAT and clinical operations.

• Recruiting & Retaining More Patients Per Site:

  Through Home Trial Support (HTS) services, MRN is able to enhance the accessibility of clinical trials while reducing the emotional toll on their patients suffering from loss of mobility.

• The Secret Sauce Behind High-Enrolling PIs

  The real challenge with enrollment often comes at the screening stage, where PI prioritization, site bandwidth, and sponsor support guide how many patients actually make it onto a study.

• How Modern RTSM Platforms Are Eliminating Delays

  Stop letting rigid legacy RTSM systems stall your clinical trials. Learn why manual change requests cause months of delays and how a modern, platform-based approach restores your study’s agility.

• How To Reduce Patient Dropout Rates In Clinical Trials

  2/11/2026

  Sponsors are addressing patient dropout rates by shifting from reactive troubleshooting to proactive protocol designs that minimize participant burden.

• RTSM Reusability: What It Is, Why Most Systems Lack It, And Why It Matters

  2/25/2026

  Explore why RTSM should be viewed as a system for managing change. Learn how platform-based reusability reduces UAT churn, preserves institutional memory, and stabilizes mid-study amendments.

• Virtual eConsent For Decentralized Trials

  12/23/2025

  Virtual eConsent improves accessibility and compliance in decentralized trials, streamlining enrollment with a secure, user-friendly process for informed consent in remote research.

• Can Your Trial Payment Approach Stand Up To Regulatory Scrutiny?

  6/15/2026

  Fragmented trial payment systems create compliance, ethical, and operational risks. Aligning payments with regulations and ethics improves transparency, reduces burden, and supports audits and participation.

• Executing Concurrent Decentralized RCTs And RWE At Scale

  3/31/2026

  See how a team of four managed data for 40 peer-reviewed studies and 200,000 participants.